| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Landos Biopharma, Inc. | Director | Stock Option (right to buy) | 0 | May 23, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| LABP | Landos Biopharma, Inc. | May 23, 2024 | 1 | $0 | 4 | May 23, 2024 | Director |
| LABP | Landos Biopharma, Inc. | May 30, 2023 | 1 | $0 | 4 | Jun 1, 2023 | Director |
| LABP | Landos Biopharma, Inc. | May 30, 2023 | 0 | $0 | 3 | Jun 1, 2023 | Director |